- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/58 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving labelled substances
Patent holdings for IPC class G01N 33/58
Total number of patents in this class: 6643
10-year publication summary
422
|
498
|
552
|
452
|
482
|
482
|
503
|
507
|
520
|
356
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 20108 |
105 |
Life Technologies Corporation | 3318 |
85 |
Ventana Medical Systems, Inc. | 1037 |
85 |
Becton, Dickinson and Company | 7306 |
81 |
Promega Corporation | 576 |
67 |
Centre National de La Recherche Scientifique | 10564 |
64 |
Massachusetts Institute of Technology | 10115 |
62 |
F. Hoffmann-La Roche AG | 7948 |
54 |
10X Genomics, Inc. | 1253 |
46 |
Siemens Healthcare Diagnostics Inc. | 2081 |
43 |
Bio-Rad Laboratories, Inc. | 1618 |
42 |
President and Fellows of Harvard College | 6002 |
41 |
The Board of Trustees of the Leland Stanford Junior University | 6476 |
40 |
Board of Regents, The University of Texas System | 5869 |
38 |
The General Hospital Corporation | 4770 |
37 |
Roche Diagnostics Operations, Inc. | 1502 |
36 |
Purdue Research Foundation | 3673 |
36 |
Sony Group Corporation | 14275 |
36 |
The Johns Hopkins University | 5714 |
32 |
Agilent Technologies, Inc. | 2632 |
30 |
Other owners | 5583 |